Cincor Pharma Inc (CINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,750 | -37,772 | -16,697 | -50,369 | -21,025 |
| Depreciation Amortization | -427 | -177 | -37 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,653 | 1,409 | 3,683 | -3,115 | 577 |
| Other Working Capital | -16 | -4,826 | -5,247 | -871 | -3,937 |
| Other Operating Activity | 5,159 | 4,101 | 586 | 23,508 | 5,429 |
| Operating Cash Flow | $-52,381 | $-37,266 | $-17,713 | $-30,847 | $-18,955 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -105 | -42 | N/A | N/A | N/A |
| Purchase Of Investment | -335,391 | -227,226 | -159,839 | N/A | N/A |
| Sale Of Investment | 105,000 | 60,000 | 10,000 | N/A | N/A |
| Investing Cash Flow | $-230,496 | $-167,268 | $-149,839 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 441,392 | 197,767 | 197,767 | 1,404 | 1,233 |
| Other Financing Activity | -2,564 | -2,219 | -2,219 | 139,971 | 133,353 |
| Financing Cash Flow | $438,828 | $195,548 | $195,548 | $141,375 | $134,586 |
| Beginning Cash Position | 136,606 | 136,606 | 136,606 | 26,078 | 26,078 |
| End Cash Position | 292,557 | 127,620 | 164,602 | 136,606 | 141,708 |
| Net Cash Flow | $155,951 | $-8,986 | $27,996 | $110,528 | $115,630 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,381 | -37,266 | -17,713 | -30,847 | -18,955 |
| Capital Expenditure | -105 | -42 | N/A | N/A | N/A |
| Free Cash Flow | -52,486 | -37,308 | -17,713 | -30,847 | -18,955 |